The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, highlight the growing interest in mental health treatment.Read More

You might also be interested in reading Seeing red? FUD that! Here’s what you should have bought instead of Bitcoin last week.